These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29092728)

  • 21. Acotiamide: first global approval.
    Nowlan ML; Scott LJ
    Drugs; 2013 Aug; 73(12):1377-83. PubMed ID: 23881665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
    Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
    Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach.
    Yoshii K; Iikura M; Hirayama M; Toda R; Kawabata Y
    Pharm Res; 2016 Feb; 33(2):292-300. PubMed ID: 26350104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Acotiamide on the Esophageal Motility Function in Patients with Esophageal Motility Disorders: A Pilot Study.
    Muta K; Ihara E; Fukaura K; Tsuchida O; Ochiai T; Nakamura K
    Digestion; 2016; 94(1):9-16. PubMed ID: 27326454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological and clinical profile of acotiamide hydrochloride hydrate (Acofide(®) Tablets 100 mg), a novel therapeutic agent for functional dyspepsia (FD)].
    Matsunaga Y; Tanaka T; Saito Y; Kato H; Takei M
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):84-94. PubMed ID: 24531902
    [No Abstract]   [Full Text] [Related]  

  • 26. Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach.
    Ito K; Kawachi M; Matsunaga Y; Hori Y; Ozaki T; Nagahama K; Hirayama M; Kawabata Y; Shiraishi Y; Takei M; Tanaka T
    Drug Res (Stuttg); 2016 Apr; 66(4):196-202. PubMed ID: 26418413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis.
    Xiao G; Xie X; Fan J; Deng J; Tan S; Zhu Y; Guo Q; Wan C
    ScientificWorldJournal; 2014; 2014():541950. PubMed ID: 25197703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of acotiamide, an orally active acetylcholinesterase inhibitor, into the myenteric plexus of rat and dog stomachs.
    Yoshii K; Yamaguchi T; Hirayama M; Toda R; Kinomoto T; Kawabata Y; Chiba K
    Life Sci; 2016 Jan; 145():93-7. PubMed ID: 26682939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acotiamide improves stress-induced impaired gastric accommodation.
    Ikeo K; Oshima T; Sei H; Kondo T; Fukui H; Watari J; Miwa H
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27860042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the Uptake Transporter Responsible for Distribution of Acotiamide into Stomach Tissue.
    Hirayama M; Hoshino Y; Yoshii K; Toda R; Kawabata Y; Nakanishi T; Tamai I
    Mol Pharm; 2020 Apr; 17(4):1071-1078. PubMed ID: 32105080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging drugs for functional dyspepsia.
    Zala AV; Walker MM; Talley NJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):221-33. PubMed ID: 25645940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers.
    Ishimura N; Mori M; Mikami H; Shimura S; Uno G; Aimi M; Oshima N; Ishihara S; Kinoshita Y
    BMC Gastroenterol; 2015 Sep; 15():117. PubMed ID: 26362795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vonoprazan Therapy is as Effective for Functional Dyspepsia without Heartburn as Acotiamide Therapy.
    Shinozaki S; Osawa H; Hayashi Y; Miura Y; Sakamoto H; Yano T; Lefor AK; Yamamoto H
    J Gastrointestin Liver Dis; 2023 Mar; 32(1):23-29. PubMed ID: 37004225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acotiamide on gastric emptying in healthy adult humans.
    Zai H; Matsueda K; Kusano M; Urita Y; Saito Y; Kato H
    Eur J Clin Invest; 2014 Dec; 44(12):1215-21. PubMed ID: 25370953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyspepsia.
    Ford AC; Moayyedi P
    Curr Opin Gastroenterol; 2013 Nov; 29(6):662-8. PubMed ID: 24100727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.
    Kawachi M; Matsunaga Y; Tanaka T; Hori Y; Ito K; Nagahama K; Ozaki T; Inoue N; Toda R; Yoshii K; Hirayama M; Kawabata Y; Takei M
    Eur J Pharmacol; 2011 Sep; 666(1-3):218-25. PubMed ID: 21651906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats.
    Seto K; Sasaki T; Katsunuma K; Kobayashi N; Tanaka K; Tack J
    Neurogastroenterol Motil; 2008 Sep; 20(9):1051-9. PubMed ID: 18482254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia.
    van Marrewijk CJ; van Oijen MG; Paloheimo LI; Fransen GA; Mujakovic S; Muris JW; Numans ME; De Wit NJ; Grobbee DE; Knottnerus JA; Laheij RJ; Jansen JB
    Aliment Pharmacol Ther; 2009 Jul; 30(1):82-9. PubMed ID: 19309389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.